The dysregulation of alternative splicing (AS) has emerged as a mechanism of acute myeloid leukemia (AML). However. the prognostic impact of AS events remains under-explored in AML. Here we report the prognostic value of AS events and associated splicing factors based on three datasets of AML patients. https://www.marcelovicente.com/product-category/body-full/